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ABSTRACT

The invention relates to a method of identifying herbicides
and to the use of inhibitors of plant peptide deformylase as

broad spectrum herbicides.
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INHIBITORS OF PLANT PEPTIDE
DEFORMYLASE FOR USE AS
BROAD-SPECTRUM HERBICIDES AND
METHODS FOR IDENTIFYING THE SAME

bacterial enZyme Which are potentially novel and neW anti

biotic agents. Meinnel et al., Biochemistry 3814287-4295

(1999) designed and synthesiZed substrate analogue inhibi
tors of bacterial peptide deformylase and studied their capac
ity to undergo hydrolysis. To aid in the design of both the
cobalt and Zinc containing E. coli peptide deformylase, Hao
et al., Biochemistry 3814712-4719 (1999), studied the struc
ture of the protein-inhibitor complexes of the cobalt and Zinc
containing E. coli enzyme.
Prior to the present invention, it Was generally accepted
that peptide deformylase genes and proteins Were absent from

CROSS-REFERENCE TO RELATED
APPLICATIONS

This application claims priority from US. patent applica
tion Ser. No. 10/680,100, ?led Oct. 8, 2003, Which is a divi

sional application of US. patent application Ser. No. 09/617,
805, ?led Jul. 14, 2000, now US. Pat. No. 6,730,634. Each of

these prior applications is hereby incorporated by reference in
its entirety.

eukaryotic cells. The present invention unexpectedly estab
lishes, for the ?rst time, the existence of a peptide deformy
lase gene and protein in eukaryotic cells, particularly in plant

FIELD OF THE INVENTION

cells. The inventors have found that the deformylase is a novel
and suitable target for identifying neW broad spectrum herbi
cides.

The invention relates to a method of identifying herbicides
and to the use of inhibitors of plant peptide deformylase as
broad spectrum herbicides.

SUMMARY OF THE INVENTION
20

In a ?rst aspect, the present invention relates to a plant

BACKGROUND

Ribosome-mediated synthesis of proteins begins With a
methionine residue. In prokaryotes and eukaryotic organelles
(mitochondria and chloroplasts), the methionyl moiety car
ried by the initiator tRNA is N-formylated prior to its incor
poration into a polypeptide (Meinnel and Blanquet, J. Bacte
riol. 17517737-7740 (1993)). N-formylmethionine is
therefore alWays incorporated at the N-terminus of a nascent

peptide deformylase gene Which is expressed in a higher

plant. A particularly preferred higher plant is Arabidopsis.
More particularly preferred is the strainArabidopsis Zhaliana.
25

deformylase.
In another aspect, the present invention relates to a recom
30

binant vector comprising the peptide deformylase nucleotide
sequence described above.
In another aspect, the invention relates to a host cell that is
transformed or transfected With the recombinant vector of the
invention. The host cell may be a prokaryotic cell, such as a

polypeptide in prokaryotes (Adams, I. M. and Capecchi, M.,
Proc. Natl. Aca. Sci. U.S.A. 551147-155 (1966); Webster et
al., Proc. Natl. Acad. Sci. U.S.A. 551155-161 (1966)). HoW
ever, most mature proteins do not retain the N-formyl group
(Marcker, K. and Sanger, F. J. Mol. Biol. 81835-840 (1964)).
Instead, the N-formylmethionine group is removed post- or

In additional aspects, the present invention relates to a

nucleotide and amino acid sequence encoding a plant peptide

35

bacterial cell, or a eukaryotic cell, such as a plant cell or a

co-translationally in a process knoWn as deformylation,

mammalian cell.
In yet another aspect, the present invention relates to an

Which is catalyZed by peptide deformylase.
Deformylation is catalyZed by peptide deformylase Which

isolated or recombinantly expressed peptide deformylase
polypeptide Which is encoded by a plant peptide deformylase

cleaves the formyl group from the nascent polypeptide chain

40

gene as described above.

(Adams, 1., J. Mol. Biol. 331571-589 (1968); Livingston, D.
M. and Leder, P., Biochemistry 81435-443 (1969); Takeda, M.

method for introducing the plant peptide deformylase gene

and Webster, R. E., Proc. Natl. Acad. Sci. U.S.A. 6011487

into a cell Which does not express said gene, Which method

In still another aspect, the present invention relates to a

1494 (1968)).
Prior to the present invention, research in the area of pep

45

tide deformylase activity and enZymology focused on the

comprises transforming a higher plant seed crop With the
recombinant vector (vector containing a peptide deformylase
gene) such that the cell expresses the peptide deformylase

bacterial enzyme. For example, the structure of the core

enZyme encoded by the gene. The cell may be a prokaryotic

domain of E. coli peptide deformylase Was solved by NMR
(Meinnel, T. et al., J. Mol. Biol. 2621375-386 (1996)) and the

cell or a eukaryotic cell.

structure of the full-length protein by X-ray crystallography
(Chan et al., Biochemistry 36113904-13909 (1997)). Becker

In another aspect, the present invention provides a method
50

method comprising:

et al., J. Biol. Chemistry 273(19): 11413-1 1416 (1998) solved

(a) incubating a catalytically effective amount of a plant
peptide deformylase, With a suitable substrate, in the presence

the structure of the catalytically active E. coli enZyme in the

nickel-bound form (PDF-Ni) and in inhibitor-complexed
form.

of identifying an inhibitor of plant peptide deformylase, said

or absence of a candidate inhibitor compound, and
55

More recently, Ragusa et al., J. Mol. Biol. 2891 1445-1457

(b) detecting and quantifying the enZyme product formed.

(1999), investigated the substrate speci?city of Escherichia
coli peptide deformylase by measuring the ef?ciency of the

The method may further comprises comparing the amount
of enZyme product formed in the presence and absence of said

enZyme to cleave formylpeptides. Durand et al., Archives

Biochemistry and Biophysics, 367(2)1297-302 (1999), tested

60

permits identi?cation of inhibitors of peptide deformylase
derived from Arabidopsis Zhaliana.

a variety of peptide aldehydes and identi?ed calpeptin as a
potent inhibitor of E. coli and B. sublilis peptide deformylase.
The overall focus in the ?eld has been engineering site

The invention also provides a method of identifying herbi
cides Which comprises testing a compound in a peptide

speci?c inhibitors of peptide deformylase With a goal of
developing broad-spectrum antibiotics With loW to no mam

malian toxicity. Rajagopalan et al., Biochemistry 36113910
13918 (1997), identi?ed speci?c and potent inhibitors of the

candidate inhibitor.
In a preferred embodiment, the method of the invention

65

deformylase inhibition assay, and Where a measurable reduc

tion of plant peptide deformylase is observed, subjecting the
compound to an in vivo test for herbicidal activity.

US 7,745,693 B2
4
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l:50,000. Inclusion bodies (50 ng) used as antigen in making
the antibody Were included in the standard lane (lane 1).
FIG. 5 shoWs ten-day old pea plants 48 hours after appli

In another aspect, the invention relates to herbicides Which

act by inhibiting plant peptide deformylase and Which are
identi?ed by the methods of the invention.
cide, Wherein said herbicide is a compound Which is an

cation of actinonin (2.5 mg/ml) in 0.1% Tween-20 (left) or
treated With 0.1% Tween-20 alone (right).
FIG. 6 is a 1% agarose gel in TBE buffer containing 0.1

inhibitor of peptide deformylase. A preferred herbicide is
actinonin, Which is a potent inhibitor of plant peptide

ug/ml ethidium bromide and subjected to electrophoresis.
Amplicons of Reverse Transcriptase-Polymerase Chain

deformylase.

Reactions (RT-PCR) reactions of Atdef2 are depicted.
FIG. 7 is a 15% SDS-PAGE shoWing AtDEF2 after puri?
cation.
FIG. 8 shoWs spectrophotometric detection and quantita

In another aspect, the invention provides a method of com

bating Weeds comprising treating said Weeds With a herbi

The invention also provides a method of controlling veg

etation comprising applying to plant foliage a herbicidally
effective amount of an inhibitor of peptide deformylase.
In a further aspect, the invention provides a method of

tion of p-nitroaniline released from formyl-Met-Leu-p-ni
troanilide substrate folloWing sequential action of AtDEF2

inhibiting the activity of plant peptide deformylase compris

and Aeromonas proleolylica aminopeptidase.

ing exposing said peptide deformylase to an effective amount
of an inhibitor of said peptide deformylase.
Still further, the invention provides an antibody directed

DETAILED DESCRIPTION OF THE INVENTION

against peptide deformylase isolated from Arabidopsis
As discussed above, the present inventors have found that

Zhaliana. The antibody may be a polyclonal or a monoclonal

antibody.

20

In an additional aspect, the invention also provides a trans

genic plant, Wherein said transgenic plant is engineered to be
resistant to an inhibitor of plant peptide deformylase.
In a further aspect, the invention provides a herbicidal

composition comprising an inhibitor of plant peptide
deformylase. In accordance With the present invention, the

25

inhibitor is a herbicide, i.e. a compound having herbicidal
activity. The composition of the invention may also contain a

herbicidally acceptable surfactant.
In yet another aspect, the present invention provides a

30

method of controlling vegetation comprising applying to
plant foliage a herbicidal composition, Wherein said herbi
cidal composition comprises an inhibitor of plant peptide
deformylase. Those of skill in the art Would recogniZe that the
herbicide actinonin may be included in compositions of the
present invention.
Additional aspects of the invention Will be described

identifying neW broad spectrum herbicides. The identi?ca
tion of this neW target has Widespread implications in the
agricultural area. Methods of identifying inhibitors of this
target Will be useful for identifying neW broad spectrum her
bicides, Which Will be used to control the groWth of Weeds.
Chemical Weed control using herbicides is a poWerful tool in
the modern technological age. In fact, it has become almost a
universal practice to use herbicides to control groWth of unde
sirable vegetation such as Weeds or plants.
A particularly useful type of herbicide is one having a

broad spectrum of herbicidal activity. The use of broad spec
trum herbicides offers the advantage of obviating the need for
35

multiple herbicides. Since some Weeds are resistant to herbi
cides, clearly there is a need for the identi?cation of neW

targets of inhibition and for identi?cation and production of
effective herbicides that inhibit such targets.
The present invention is based, at least in part, on the
discovery of a plant nuclear gene that encodes a chloroplast

throughout the speci?cation.
BRIEF DESCRIPTION OF THE FIGURES

plant cells contain a peptide deformylase gene and protein,
and the deformylase provides a novel and suitable target for

40

targeted peptide deformylase polypeptide. Utilizing
sequence data obtained from the Arabidopsis genome

sequencing project (Accession Number AC 007591), the

FIG. 1A shoWs a CLUSTAL W (1.8) alignment ofArabi

dopsis (truncated to the ChloroP predicted transit peptide)

present inventors have isolated a cDNA from Arabidopsis

SEQ ID NO: 8 and E. coli SEQ ID NO: 7 peptide deformylase

proteins.

45

FIG. 1B shoWs a CLUSTAL W (1.8) alignment ofArabi

deduced translation of this DNA sequence revealed the pres
ence of all three conserved protein motifs associated With

dopsis (truncated to the ChloroP predicted transit peptide)
SEQ ID NO: 8 and Chlamydia peptide deformylase proteins
SEQ ID NO: 10. All three conserved proteins motifs found in
prokaryotic sequences are present in the Arabidopsis peptide

prokaryotic peptide deformylase. (See FIG. 1B for sequence

alignment.)
50

deformylase (AtDEFl).
FIG. 2 is a gel shoWing an amplicon of the expected siZe,
630 bp, Which Was created When Arabidopsis RNA Was

reversed-transcribed and Atdefl ampli?ed With gene speci?c

primers (RLH 146X147).

55

FIG. 3 shoWs the results of in vitro import of Arabidopsis

tion are polynucleotide sequences encoding a plant peptide
deformylase Which have substantial identity to the polynucle

processing to a mature form once inside the plastid. The 5.5
60

(23.4 kD) forms Was observed after 15 and 30 minutes after

initiation of the assay. Only the processed protein Was present
after ther'molysin treatment of the chloroplasts after 30 min
utes of import.
FIG. 4 shoWs detection of an expected siZe protein from
~100 ug Arabidopsis total protein extract (soluble, lane 2;

insoluble, lane 3) by AtDEFl antibody (Rabbit 95728) at.

Thus, the present invention provides a plant peptide
deformylase gene Which is expressed in higher plants. A
particularly preferred higher plant is Arabidopsis. More par
ticularly preferred is the strain Arabidopsis Zhaliana.
The invention also provides polynucleotide sequences
Which encode a plant peptide deformylase. In particular, the
invention encompasses the polynucleotide sequences of
Atdefl and Atdef2 genes. Also Within the scope of the inven

Zhaliana deformylase (AtDEFl) protein into isolated pea
chloroplasts under standard, in vitro import conditions and
kD shift from predicted precursor (28.9 kD) to processed

Zhaliana that encodes peptide deformylase. The gene has
substantial homology to bacterial peptide deformylase. The

otide sequence of Atdef1 or Atdef2. Such polynucleotide
sequences are readily identi?able by those skilled in the art

using techniques knoWn in the art such as site-speci?c

mutagenesis and hybridization technology, such as hybrid
iZation under stringent conditions.
65

The invention further provides an isolated and puri?ed

polynucleotide sequence Which hybridiZes under stringent
conditions to the polynucleotide encoding the polypeptide

US 7,745,693 B2
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comprising the amino acid sequence of AtDEFl or AtDEF2

A cDNA for a peptide deformylase, such as anArabidopsis

or a fragment thereof, as Well as an isolated and puri?ed

peptide deformylase cDNA, may be engineered and inserted

polynucleotide Which is complementary to the polynucle
otide encoding the polypeptide comprising the amino acid

into bacterial expression vectors to verify functional activity,

sequence of AtDEFl or AtDEF2 or a fragment thereof.

the protein for crystallization attempts and acquisition of

The invention also provides an isolated and puri?ed poly
nucleotide sequence comprising the polynucleotide sequence

antibodies.

subcellular localiZation, and to generate a suitable amount of

Production of a recombinant plant peptide deformylase
polypeptide may be achieved by a method comprising:

of Atdefl or a fragment thereof, and an isolated and puri?ed

polynucleotide variant having at least 70% polynucleotide
sequence identity to the polynucleotide comprising the poly

(a) transforming a suitable host cell With a vector compris

ing a gene encoding a plant peptide deformylase polypeptide,
the gene being operably linked to suitable regulatory

nucleotide sequence of Atdefl or Atdef2 or a fragment

thereof. The invention also provides an isolated and puri?ed
polynucleotide having a sequence complementary to the

sequences;

polynucleotide comprising the polynucleotide sequence of

the peptide deformylase is expressed.

(b) groWing the transformed cell under conditions Where
To obtain a peptide deformylase polypeptide, recombinant

Atdefl or Atdef2 or a fragment thereof.

host cells expressing the peptide deformylase polypeptide

Amino acid sequences encoding a plant peptide deformy
lase are also Within the purvieW of the present invention. Such

may be groWn in a conventional manner in a suitable culture

amino acids sequences include but are not limited to the

medium and then lysed using conventional means such as
enZymatic degradation or detergents or the like. The
expressed protein may be isolated as an insoluble inclusion

amino acid sequences of AtDEFl and AtDEF2.

Additionally, and of equal importance, the inventors have

20

body. Alternatively, the protein can be separated and puri?ed

identi?ed a putative N-terminal targeting sequence for chlo
roplasts. (FIGS. 1a and 1b) Thus, perhaps as a remnant of its

by standard chromatography techniques.
Transformation of a nucleic acid molecule into a cell can be

prokaryotic origins, the chloroplast has retained N-formyl
methionine as its initiator of protein translation.
The present invention is based on a novel herbicidal mode

accomplished by any method by Which a nucleic acid mol
25

of action, i.e., inhibition of plant peptide deformylase. Dis

microinj ection, lipofection, adsorption, and protoplast

covery of this novel mode of action opens up the opportunity
for identifying novel chemicals that inhibit the enZyme target
either directly or folloWing metabolism to an active inhibitor

in plants (“indirect inhibitors”).

fusion.
30

Would recognize that the host cell encompassed by the present
invention may be a prokaryotic cell, such as a bacterial cell, or
a eukaryotic cell, such as a plant cell or a mammalian cell.
35

Thus, the invention relates to the identi?cation of com
pounds, as Well as the development of neW compounds

One type of recombinant vector, referred to herein as a

peptide deformylase, for use as broad spectrum herbicides.

plants.
More speci?cally, the invention relates to a method of

40

45

replicating Within the host cell. Expression vectors can be
either prokaryotic or eukaryotic, and are typically viruses or
50

(b) detecting and quantifying the enZyme product formed.
The method may further comprise comparing the amount
of enZyme product formed in the presence and absence of said
55

60

Wood and softWood trees, forage grasses, pea, canola, ?ax,
tomato, sugar beet, potato, rice, lettuce and radish.
The invention employs an isolated or recombinantly

expressed plant peptide deformylase polypeptide encoded by
a plant peptide deformylase gene. The invention also encom
passes variants of this polypeptide, and particularly those

Which retain peptide deformylase activity.

plasmids. Expression vectors of the present invention include
any vectors that function (i.e., direct gene expression) in
recombinant cells of the present invention, including in bac

terial, fungal, endoparasite, insect, other animal, and plant

as inhibitors of peptide deformylase derived from otherplants
including, but not limited to, soybean, sun?ower, cotton,

corn, tobacco, alfalfa, Wheat, barley, oats, sorghum, hard

such that the molecule is able to be expressed When trans
formed into a host cell. As used herein, an expression vector
is a DNA or RNA vector that is capable of transforming a host

cell and of effecting expression of a speci?ed nucleic acid
molecule. Preferably, the expression vector is also capable of

(a) incubating an effective amount of a plant peptide

candidate inhibitor.
The invention permits identi?cation of inhibitors of pep
tide deformylase derived from Arabidopsis Zhaliana as Well

recombinant molecule, comprises a nucleic acid molecule of
the present invention operatively linked to an expression vec
tor. The phrase operatively linked refers to insertion of a
nucleic acid molecule into an expression vector in a manner

identifying an inhibitor of plant peptide deformylase, said
method comprising:
deformylase, With a suitable substrate, in the presence or
absence of a candidate inhibitor compound; and

Suitable expression vectors are knoWn and routinely used
in the art and may include, but are not limited to, pLEX and

pET.

capable of acting as highly speci?c inhibitors of chloroplastic
The invention provides a method of identifying potential
herbicides Which comprises testing a candidate in a peptide
deformylase assay for direct and indirect inhibitors. Indirect
inhibitors are those inhibitors that require conversion in

Suitable host cells are knoWn to those of skill in the art and
include, but are not limited to bacterial cells such as BL21

(DE3)pLysS, BL21(DE3), and GI724. Those of skill in the art

Because all non-parasitic plants contain chloroplasts, and
deletion and/or mutation of peptide deformylase in prokary
otic organisms is lethal, it is expected that inhibition of pep
tide deformylase activity in the chloroplast Will be lethal to

plants.

ecule can be inserted into the cell. Transformation techniques
include, but are not limited to, transfection, electroporation,

65

cells. Preferred expression vectors of the present invention
can direct gene expression in bacterial, yeast, insect and
mammalian cells and more preferably in the cell types dis
closed herein.
In particular, expression vectors of the present invention
contain regulatory sequences such as transcription control
sequences, translation control sequences, origins of replica
tion, and other regulatory sequences that are compatible With
the recombinant cell and that control the expression of nucleic
acid molecules of the present invention. In particular, recom
binant molecules of the present invention include transcrip
tion control sequences. Transcription control sequences are
sequences Which control the initiation, elongation, and termi

nation of transcription. Particularly important transcription

US 7,745,693 B2
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control sequences are those Which control transcription ini

of plant peptide deformylase is observed, subjecting the can

tiation, such as promoter, enhancer, operator and repressor
sequences. Suitable transcription control sequences include

herbicidal activity.

didate inhibitor to conventional test(s) to con?rm the in vivo

any transcription control sequence that can function in at least
one of the recombinant cells of the present invention. A vari
ety of such transcription control sequences are knoWn to those
skilled in the art. Preferred transcription control sequences

A measurable reduction includes a reduction that is statis

tically signi?cant, statistically signi?cant being de?ned as the
results from analysis of variance Where the F-ratio, LSD

(least signi?cant difference), orthogonal/non-orthogonal

include those Which function in bacterial, yeast, insect and
mammalian cells, such as, tac, lac, trp, trc, oxy-pro, omp/lpp,
rmB, bacteriophage lambda (such as lambda PL and lambda

comparison, or any other statistical technique for mean sepa
ration, that indicates the means are different at 0.05 or 0.01

level. In one embodiment of the invention, the measurable
reduction is at least 10%.

PR and fusions that include such promoters), bacteriophage

T7, T7lac, bacteriophage T3, bacteriophage SP6, bacterioph

Conventional tests for con?rming in vivo herbicidal activ
ity include, but are not limited to, detecting decreases in fresh

age SP01, metallothionein, alpha-mating factor, Pichia alco
hol oxidase, alphavirus subgenomic promoters (such as Sind
bis virus subgenomic promoters), antibiotic resistance gene,
baculovirus, Heliolhis Zea insect virus, vaccinia virus, herp
esvirus, raccoon poxvirus, other poxvirus, adenovirus,
cytomegalovirus (such as intermediate early promoters), sim
ian virus 40, retrovirus, actin, retroviral long terminal repeat,
Rous sarcoma virus, heat shock, phosphate and nitrate tran

Weight, dry Weight, chlorophyll, protein, and germination.
Typical symptoms resulting from treatment of plant foliage
With herbicides are cessation of groWth folloWed by chlorosis
and necrosis.

Although in vitro peptide deformylase assays Will identify
20

scription control sequences as Well as other sequences

activity. Accordingly, the invention further relates to a method
of identifying potential herbicides that can be metaboliZed to

capable of controlling gene expression in prokaryotic or
eukaryotic cells. Additional suitable transcription control
sequences include tissue-speci?c promoters and enhancers as

Well as lymphokine-inducible promoters (e.g., promoters
inducible by interferons or interleukins).
Puri?ed peptide deformylase is highly active toWard

25

N-formylated peptide substrates, thus rendering these pep
tides suitable for use in the methods of the present invention.
Suitable substrates include, but are not limited to formylated

intrinsic herbicidal activity, it may in some cases be necessary
to use conventional, tests to con?rm the in vivo herbicidal

30

dipeptides and formyl-Met-Leu-p-nitroanilide as described

an inhibitor of peptide deformylase in plants Which comprises
testing a compound in a peptide deformylase assay, and
Where a measurable reduction of plant peptide deformylase is
observed, subjecting the compound to conventional test(s) to
con?rm the in vivo herbicidal activity.
Of course, those skilled in the art Would appreciate that the
invention encompasses herbicides identi?ed by the methods
of the invention. The invention also includes the use as a

by Wei and Pei, Analytical Biochemistry 250:29-34 (1997)

herbicide of a compound Which is an inhibitor of plant peptide
deformylase, With the proviso that the compound is not a

and other formylated peptides as described by Raj agopalan et

general enZyme inhibitor.

al., Biochemistry 36:13910-13918 (1997).
Peptide deformylase activity may be assessed by detecting

Still further, the invention relates to a method of combating
35

Weeds comprising treating said Weeds With a herbicide,

and quantifying the amount of enZyme product formed in the

Wherein said herbicide is a compound Which is an inhibitor of

method of the invention. Speci?cally, peptide deformylase
activity can be quanti?ed by measuring the amount of

peptide deformylase in plants.

released p-nitroaniline (end product) from formyl-Met-Leu

etation comprising applying to plant foliage a herbicidally

p-nitroanilide using a coupled enZyme assay WithAeronomo

The invention also relates to a method of controlling veg
40

nasproleolylica aminopeptidase. This permits assessment of
the catalytic properties of peptide deformylase using a series

Since bacterial peptide deformylase is a metallo hydrolase,
compounds containing a metal ion chelating group are poten
tial inhibitors of the enZyme. These compounds may also

of synthetic N-formylated peptides as substrates in a continu

ous spectrophotometric assay. (Wei and Pei, Analytical Bio
chemistry 250:29-34 (1997)). A continuous spectrophoto
metric assay may be used to monitor plant peptide
deformylase activity, i.e., to detect and quantify the enZyme
product formed in the method of the invention. Alternatively,

inhibit plant peptide deformylase and are encompassed With
the scope of the present invention.
Examples of inhibitors of the invention include, but are not

limited to, divalent metal chelators, dithiol compounds such
as 1,2-ethanedithiol, 1,3-propanedithiol, 2,3-dimercapto-1

a discontinuous spectrophotometric assay may also be used.

The presence of peptide deformylase protein may be
assessed using immunological methods, such as by using
antibody directed to the protein or a part thereof, and by
knoWn enzymatic assays, such as peptide deformylase activ
ity assays as described above. Coupled deformylase assays
may also be used for measuring enZymatic activity and inhi
bition thereof as described by Rajagopalan et al., Biochem

50

propanesulfonic acid and 1,5-pentanedithiol.
Also included are divalent metal-chelating agents such as

55

EDTA, thiophenol and thio-speci?c agents [p-(chloro mer
curi)-benZoate] and iodoacetate.
Also included are 7,8 benZoquinoline, methyl 2-(sulfanyl

methyl) hexanoate (TN) and imino[(5-methoxy-5-oxo-4-[2

sulfanylmethyl)-hexanoyl]amino pentyl) amino]methamine
(TNR).

The invention also relates to a method of inhibiting the
60

said peptide deformylase to an effective amount of an inhibi
tor of said peptide deformylase. An effective amount of an

The inhibitors of the invention may be substrate analogue

inhibitors such as thiophan (3 -mercapto-2-benZylpro

panoylglycine) and captopril (3 -mercapto-2-methylpro

inhibitor is the concentration of the inhibitor that is required

to reduce plant peptide deformylase activity.
The invention also relates to a method of identifying her
bicides Which comprises testing a candidate inhibitor in a
peptide deformylase assay, and Where a measurable reduction

propanol, 2,3-dimercapto-1-propanol, 2,3-dimercapto-1
1,10-phenanthroline, 2-mercapto ethanol, glutathione,

istry 36: 13910-13918 (1997).

activity of plant peptide deformylase comprising exposing

effective amount of an inhibitor of peptide deformylase.

65

panoyl proline), or other types of enZyme inhibitors knoWn in
the art. Such inhibitors may be designed and/or synthesiZed
using methods knoWn in the art, including transition-state
analogue chemistry, such as used by Pei et al. (Dept. of

Chemistry, The Ohio State University, Columbus, Ohio).
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aldehydes, including those described by Durand et al.,

on site to achieve the appropriate dosage. Use of the solid or
liquid concentrates of this invention is preferable as it is a

Archives Biochemistry and Biophysics, 367(2):297-302

much simpler operation and minimiZes the possibility of

(1999), as inhibitors of bacterial peptide deformylase.
Given the absence of a protein crystal structure for plant
peptide deformylase, Which has a speci?c and unique amino

be introduced into the ?nal solution at the time the concen
trate is blended With Water to form the diluted solution for

Also included as inhibitors of the invention are peptide

blending errors. Moreover, if desired, other components can

application to the foliage.

acid sequence different from any previously described pep
tide deformylase, inhibitors of the invention may also include

The importance of peptide deformylase to the Well being of
plants has been demonstrated by the potent herbicidal effects

The herbicides of the invention may be applied With a
surfactant in order to improve leaf Wetting and assist in pen
etration of the active ingredient into the leaf. The surfactant is
typically an inert ingredient in the formulation. Surfactants of
virtually any class may be used. Examples of surfactants
Which may be useful include StilWet, TWeen, polyalkylene

obtained When the enZyme is inhibited. Recent studies have
shoWn the fungal product, actinonin, to be an inhibitor of

glycols (such as polyethylene glycols), alkanolamides,
betaine derivatives, ethoxylated propoxylated block copoly

bacterial peptide deformylase (Chen et al., Biochemistry,
39(6):1256-1263 (2000). A role for peptide deformylase in

mers, glycerol esters, glycol esters, imidaZolines and imida
Zoline derivatives, lanolin derivatives, lecithin derivatives,

plant groWth Was suggested from analysis of the effects of the
application of actinonin, on the groWth of pea plants.
As shoWn in FIG. 5 and Example 5, observable alterations

tertiary or quaternary polyoxyalkylene alkylamines, poly
oxyalkylene and non-polyoxyalkylene alkylamine oxides,

novel compounds.
Those of skill in the art Would recognize that the inhibitors
of the invention may be used as non-selective herbicides.

20

in plant groWth, i.e., stunting and yelloWing of pea plants,

non-alkoxylated sorbitan esters, alkyl glycosides, alkyl

Were evident in the presence of actinonin. Nearly complete
inhibition of peptide deformylase activity Was observed in an

in vitro peptide deformlyase inhibition assay. (FIG. 8 and
Example 8) This data establishes that the potent herbicidal
activity of actinonin is due to inhibition of peptide deformy

polyglycosides, sucrose esters, sucrose glycerides, alkyl sul
25
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The inhibitors of the invention may be formulated as her

Effective concentrations of the herbicides and herbicidal
compositions and formulations of the invention may be

mulated in a conventional manner using an inhibitor of plant
35

dispersants. The herbicidal composition can be formulated as
a Wettable poWder, pellets, granules or dust or as a liquid
formulation With aqueous or non-aqueous solvents as a foam,

gel, suspension, or concentrate.
A method for controlling the groWth of Weeds in accor
dance With this invention can comprise applying (e. g., spray
ing), to a locus (area) to be protected, an herbicidally effective

45

ligands in, for example, cells, cell-free preparations, chemical
50

55

?nal solution for application to the foliage as by spraying.
LikeWise the herbicidal and the plant groWth regulant com
60

a poWder or granular concentrate) or With more Water (if a

alternatively, can be formed on site by mixing the ingredients
separately and/ or in sub-combinations With suf?cient Water

Accordingly, the invention provides a method of screening
compounds to identify those Which block (antagonist) the
action of peptide deformylase polypeptides. The method of
screening may involve high-throughput techniques. For
example, to screen for antagonists, a synthetic reaction mix, a
cellular compartment, such as a membrane, cell envelope or
cell Wall, or a preparation of any thereof, comprising a peptide
deformylase polypeptide and a labeled substrate or ligand of
such polypeptide is incubated in the absence or the presence
of a candidate molecule that may be a peptide deformylase

antagonist. The ability of the candidate molecule to antago
niZe the peptide deformylase polypeptide is re?ected in
decreased binding of the labeled ligand or decreased produc

dilute aqueous solutions are preferably formed simply by
suitably diluting a concentrate of this invention With Water (if

liquid concentrate) to achieve the appropriate dosage, but

libraries, and natural product mixtures. These substrates and
ligands may be natural substrates and ligands or may be
structural or functional mimetics. See, e.g., Coligan et al.,

Current Protocols in Immunology 1(2): Chapter 5 (1991).

invention include aqueous concentrates Which can be shipped
and stored until diluted With more Water on site to produce the

positions of this invention include the more dilute aqueous
solutions for use in application to the foliage. These more

Peptide deformylase polypeptides of the invention may be
used to assess the binding of small molecule substrates and

plant vegetation pursuant to this invention recourse may be

further groWth of the vegetation is stunted, inhibited and/or
sloWed Without actually killing all of the undesired vegetation
treated With the composition.
The herbicidal and groWth regulating compositions of the

vegetation is stunted, inhibited and/or sloWed Without actu
ally killing all of the undesired vegetation treated With the

composition.
Antagonists

groWing vegetation or an area Where vegetation is to be
groWn.
It Will be appreciated that to effect control of undesired

had to herbicidal activity Whereby undesired vegetation is
killed and/or to plant groWth regulant activity Whereby the

readily determined using the methods described herein
Wherein preparations are bioassayed for their inhibitory abil
ity to knoWn preparations of peptide deformylase. In order to
control groWth of vegetation, the compositions should con
tain the amount of inhibitor required to effectuate plant

groWth regulant activity Whereby the further groWth of the
40

amount of an inhibitor of plant peptide deformylase poly
nucleotide and/or polypeptide of the invention. The locus to
be protected can include, for example, the habitat of the

fatty esters and aromatic derivatives, mixtures thereof and the
like. The surfactant is preferably StilWet. Those skilled in the
art Will recogniZe that other surfactants not included above
may also useful.

bicidal compositions. A herbicidal composition can be for

peptide deformylase polypeptide, as an active ingredient,
together With suitable carriers, diluents, emulsi?ers and/or

fates or phosphates, ole?n sulfonates, alkylaryl sulfonates,
polyoxyalkylene alkylether sulfates or phosphates, sulfosuc
cinate derivatives, sulfosuccinamates, taurates, sulfates and

sulfonates of oils, fatty acids, alcohols, alkoxylated alcohols,

lase. This mode of action has not previously been described
for herbicides.

Herbicidal Compositions

polyoxyalkylene alkylethers, polyoxyalkylene alky
larylethers, polyoxyalkylene alkylesters, alkoxylated and

65

tion of product from such substrate. Molecules that bind

gratuitously, i.e., Without inducing the effects of a peptide
deformylase polypeptide are most likely to be good antago

US 7,745,693 B2
11

12
Alternatively phage display technology may be utiliZed to

nists. Detection of the rate or level of production of product
from substrate may be enhanced by using a reporter system.
are not limited to colorimetric labeled substrate converted

select antibody genes With binding activities toWards the
polypeptide either from repertoires of PCR ampli?ed v-genes
of lymphocytes from humans screened for possessing anti

into product, a reporter gene that is responsive to changes in

def or from naive libraries (McCafferty, J. et al., Nature 348:

peptide deformylase polynucleotide or polypeptide activity,

552-554 (1990); Marks, J. et al., Biotechnology 10:779-783
(1992)). The a?inity of these antibodies can also be improved
by chain shuf?ing (Clackson, T. et al., Nature 352:624-628

Reporter systems that may be useful in this regard include but

and binding assays knoWn in the art.
Another example of an assay for peptide deformylase
antagonists is a competitive assay that combines peptide

(1 991)).
If tWo antigen binding domains are present each domain
may be directed against a different epitopeitermed ‘bispe

deformylase and a potential antagonist With peptide deforrny

lase-binding molecules, recombinant peptide deformylase
binding molecules, natural substrates or ligands, or substrate
or ligand mimetics, under appropriate conditions for a com

ci?c’ antibodies.
The above-described antibodies may be employed to iso

petitive inhibition assay. Peptide deformylase can be labeled,

late or to identify clones expressing plant peptide deformy
lase polypeptides and to purify the polypeptides by a?inity

such as by radioactivity or a calorimetric compound, such that
the number of peptide deformylase molecules bound to a
binding molecule or converted to product can be determined
accurately to assess the effectiveness of the potential antago
nist.

Potential antagonists include small organic molecules,

chromatography.
Transgenics
20

peptides, polypeptides and antibodies that bind to a poly
nucleotide or polypeptide of the invention and thereby inhibit
or extinguish its activity. Potential antagonists also may be
small organic molecules, a peptide, a polypeptide such as a
closely related protein or antibody that binds the same sites on
a binding molecule, such as a binding molecule, Without

25

As With other broad spectrum herbicides, such as glypho
sate, overexpression or expression of altered forms of peptide

deformylase in plants using conventional transformation
techniques might generate plants resistant to the adverse
effects of peptide deformylase inhibitors.
Thus, the invention further relates to a transgenic plant,
Wherein said plant is engineered to be resistant to inhibitors of

plant peptide deformylase. In a further aspect, the present
invention relates to a recombinant or transgenic plant trans

inducing peptide deformylase-induced activities, thereby

binds to and occupies the binding site of the polypeptide

formed With a peptide deformylase gene such that the
deformylase is over expressed.
Additionally, sense and antisense forms of the Arabidop
sis, as Well as bacterial peptide deformylases, may be engi
neered into plant transformation vectors for the construction

thereby preventing binding to cellular binding molecules,
such that normal biological activity is prevented. Examples of

of transgenic plants With up- and doWn-regulated levels of
peptide deformylase, for testing as resistant and susceptible

preventing the action of peptide deformylase by excluding
deformylase from binding.

30

Potential antagonists also include a small molecule that

small molecules include but are not limited to small organic

35

molecules, peptides or peptide-like molecules. Other poten
tial antagonists include antisense molecules (see Okano, J.
Neurochem. 56:560 (1991); Oligodeoxynucleotides as Anti
sense Inhibitors of Gene Expression, CRC Press, Boca Raton,
Fla. (1988), for a description of these molecules). Preferred

potential antagonists include compounds related to and vari
ants of peptide deformylase.
Antibodies
The present invention further relates to an antibody

directed against plant peptide deformylase. In this regard, the

A variety of techniques may be used to introduce foreign
genes into plant cells. One common method used to introduce

foreign genes into plant cells is transformation With disarmed

Agrobaclerium, a relatively benign natural plant pathogen.
40

cell. Methods for transferring foreign genes into plant cells
and the subsequent expression of the inserted genes in plants
45

bodies immunospeci?c for such polypeptides. “Antibodies”

ies, chimeric, single chain, simianiZed antibodies and human

50

iZed antibodies, as Well as Fab fragments, including the prod
ucts of an Fab immunoglobulin expression library.

(See, e.g., De Block et al., The EMBO Journal 3: 1681 (1984);
Horsch et al. Science 227:1229 (1985); and C. L. Kado (Crit.
Rev. Plant. Sci. 10:1 (1991)).
The technique knoWn as microproj ectile bombardment has
been successfully used to introduce genes encoding neW
genetic traits into a number of crop plants, including cotton,

(See for example, US. Pat. No. 4,945,050, issued to Sanford;
Sanford et al., Trends in Biotechnology 6:299 (1988); San
55

or epitope-bearing fragments, analogues or cells to an animal

using routine protocols. For preparation of monoclonal anti
bodies, any technique knoWn in the art that provides antibod
ies produced by continuous cell line cultures can be used.
Examples include various techniques, such as those in
Kohler, G. and Milstein, C., Nature 256:495-497 (1975);
KoZbor et al., Immunology Today 4:72 (1983); Cole et al.,
Monoclonal Antibodies and Cancer Therapy, Alan R. Liss,
Inc., pg. 77-96 (1985).
Techniques for the production of single chain antibodies
(US. Pat. No. 4,946,778) can be adapted to produce single
chain antibodies to polypeptides of this invention.

regenerated from transformed cells are Well knoWn in the art.

maiZe, tobacco, sun?owers, soybeans and certain vegetables.

Antibodies generated against the polypeptides of the
invention can be obtained by administering the polypeptides

A grobaclerium actively mediates transformation eventsithe
integration of a gene providing a desired phenotypic traitias
part of the natural process it utiliZes When it infects a plant

polypeptides of the invention or variants thereof, or cells
expressing them can be used as an antigen to produce anti

as used herein includes monoclonal and polyclonal antibod

plant species to peptide deformylase inhibitors.

ford et al., Part. Sci. Technol. 5:27 (1988); J. J. Finer and M.

D. McMullen, Plant Cell Reports 8:586-589 (1990); and Gor
don-Kamm, The Plant Cell 2:603 (1990)).

Organogenesis, the development of plantlets from speci?c
plant structures such as leaf disks or root tips, has been used
60

to regenerate plants folloWing transformation. An alternative
approach has been described by Feldman, Who has shoWn that
it is feasible to vacuum in?ltrate the ?oral meristems of small

65

plants, or in the case of Arabidopsis, the entire plant With
A grobaclerium and obtain transgenic progeny. See K. A.
Feldman et al., “A grobaclerium-Mediated Transformation of

Germinating Seeds of Arabidopsis Zhaliana: A Non-Tissue
Culture Approach,” Mol. Gen. Genet. 308:1-9 (1987).
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The use of speci?c herbicides relies on differential uptake
and/ or metabolism between Weed and crop plant or on appli
cation of the herbicide before planting in a ?eld. Herbicide
tolerant plants/ crops can be created by either of three strate

17(2):477-498 (1989)) Without changing signi?cantly the
deformylase proteins of the invention can be evaluated, using

gies: i) increasing the level of the target enzyme for the

methods knoWn in the art.

encoded amino acid sequence.

Furthermore, the binding properties of the peptide

herbicide (See, eg US. Pat. No. 4,940,835, issued to Shah et
al.), ii) expressing a mutant enzyme that is not affected by the

The peptide deformylase gene part or its equivalent, pref
erably a peptide deformylase chimeric gene, encoding a vari
ant of the peptide deformylase, can be stably inserted in a

compound (Comai, L., et al., Nature 317:741-744 (1985)), iii)
expressing an enzyme that detoxi?es the herbicide (De Block,
M., et al., EMBO J. 6:2513-2518 (1987), Stalker, D. M., et al.,
Science 242:419-423 (1988)), or iv) knocking out or anti
sense doWn regulation of the plant formyl transferase gene.

conventional manner into the nuclear genome of a single

plant cell, and the transformed plant cell can be used in a
conventional manner to produce a transformed plant that is
resistant to a peptide deformylase inhibitor.
In this regard, a disarmed Ti-plasmid, containing the pep

With the ?rst approach, i), a cDNA encoding plant peptide
deformylase may be transferred into a plant in order to over

tide deformylase gene or part thereof, in Agrobaclerium
Zumefaciens can be used to transform the plant cell, and

express the deformylase enzyme. Over expression of the
enzyme alloWs the transgenic plants to groW in the presence
of higher levels of the herbicide that kills the Wild-type or

thereafter, a transformed plant can be regenerated from the

transformed plant cell using the procedures described. For
example, preferred Ti-plasmid vectors each contain the pep

non-transgenic plants.
With approach ii), herbicide-tolerant plants are created by
use of mutant forms of the plant or bacterial peptide deformy
lase that are less sensitive to inhibition by the herbicide.
Genes encoding these mutants may be cloned and expressed

20

in plants. The transgenic plants should exhibit tolerance to
levels of herbicide that kill Wild-type plants.

Plant peptide deformylase is synthesized in the cytoplasm
and translocated to the chloroplast by proteins that recognize
and bind the amino -terminal region (transit peptide). In order
to target the bacterial peptide deformylase to chloroplasts, a
gene segment encoding the plant transit peptide may be fused
to the coding sequence for the bacterial enzyme.

procedures such as direct gene transfer, pollen-mediated
25

30

The third approach for creating herbicide-tolerant plants
employs transgenic expression of enzymes that convert the
herbicide to a form that is not toxic to the plant. Some plants
have their oWn detoxifying systems for certain herbicides.

Some bacteria have been found that naturally degrade herbi

transformation, plant RNA virus-mediated transformation,
liposome-mediated transformation, and other methods such
as the recently described methods for transforming certain
lines of corn (Fromm et al., Bio/Technology 8:833-839
(1990); Gordon-Kamm et al., The Plant Cell 2:603-618
(1990)) and rice (Shimamoto et al., Nature 338:274-276

(1989); Datta et al., Bio/Technology 8:736-740 (1990)) and
the recently described method for transforming monocots

generally (PCT publication W0 92/ 09696).
The resulting transformed plant can be used in a conven
35

tional plant breeding scheme to produce more transformed
plants With the same characteristics or to introduce the pep
tide deformylase gene part in other varieties of the same or

cides.

The fourth approach for creating herbicide tolerant plants
draWs from bacterial systems Where knock-out of the formyl
transferase gene, Which codes for the formyl transferase
enzyme responsible for the formation of N-for'mylmethion

tide deformylase gene or part thereof betWeen the border
sequences, or at least located to the left of the right border
sequence, of the T-DNA of the Ti-plasmid. Of course, other
types of vectors can be used to transform the plant cell, using

related plant species. Seeds, Which are obtained from the

transformed plants, contain the peptide deformylase gene
40

part as a stable genomic insert. Cells of the transformed plant
can be cultured in a conventional manner to produce the

ine, results in the formation of a cell line that While sloW in

peptide deformylase protein Which can be recovered for use

groWth, is no longer susceptible to peptide deformylase

in methods of identifying herbicidal compounds.
The peptide deformylase gene or gene part, preferably the

inhibitors or mutations in the peptide deformylase gene.
In order to express all or an effective part of the DNA

45

sequence encoding a peptide deformylase protein of this
invention in E. coli and in plants, suitable restriction sites can
be introduced, ?anking the DNA sequence. This can be

preferably accomplished by inserting the peptide deformy

accomplished by site-directed mutagenesis, using Well
knoWn procedures (Stanssens et al., Nucleic Acids Research

truncated peptide deformylase gene, may be inserted in a
plant cell genome so that the inserted gene is doWnstream
(i.e., 3') of, and under the control of, a promoter Which can
direct the expression of the gene part in the plant cell. This is

50

lase chimeric gene in the plant cell genome; particularly in the

12:4441-4454 (1989); White et al., Trends in Genet. 5:185

nuclear genome. Preferred promoters include: the strong con

189 (1989)). In order to obtain improved expression in plants,

stitutive 35S promoters (the “35S promoters”) of the cauli
?oWer mosaic virus (CaMV) of isolates CM 1841 (Gardner et
al., Nucleic Acids Research 9:2871-2887 (1981)), CabbB-S

the codon usage of the peptide deformylase gene or effective
peptide deformylase gene part of this invention can be modi
?ed to form an equivalent, modi?ed or arti?cial gene or gene 55

part, or gene parts can be inserted in the chloroplast genome

and expressed there using a chloroplast-active promoter (e.g.,
McBride et al., Bio/Technology 13:362 (1995)). For obtain

Christensen et al., Plant Mol. Biol. 18:675-689 (1992), see

ing enhanced expression in monocot plants such as com, a
monocot intron also can be added to the chimeric gene, and

60

the DNA sequence of the peptide deformylase gene or part
thereof can be further changed in a translationally neutral

manner, to modify possibly inhibitory DNA sequences
present in the gene or gene part by means of site-directed

intron insertion and/or by introducing changes to the codon
usage, e.g., adapting the codonusage to that most preferred by
the speci?c plant (Murray et al., Nucleic Acids Research

(Franck et al., Cell 21:285-294 (1980)) and CabbB-Jl (Hull
and HoWell, Virology 86:482-493 (1987)); promoters from
the ubiquitin family (e.g., the maize ubiquitin promoter of

65

also Comejo et al., Plant Mol. Biol. 23:567-581 (1993)), the
gos2 promoter (de Pater et al., 1992), the emu promoter (Last
et al., Theor. Appl. Genet. 81:581-588 (1990)), rice actin
promoters such as the promoter described by Zhang et al., The
Plant Cell 3:1155-1165 (1991); and the TR1' promoter and
the TR2' promoter (the “TR1' promoter” and the “T2' pro
moter”, respectively) Which drive the expression of the 1' and
2' genes, respectively, of the T-DNA (Velten et al., EMBO J.

3:2723-2730 (1984)).

US 7,745,693 B2
15

16

Alternatively, a promoter can be utilized Which is not con
stitutive but rather is speci?c for one or more tissues or organs

to determine identity are designed to give the largest match
betWeen the sequences tested. Methods to determine identity
and similarity are codi?ed in publicly available computer

of the plant (e.g., leaves and/or roots) Whereby the inserted
peptide deformylase gene part is expressed only in cells of the
speci?c tissue(s) or organ(s). For example, the peptide
deformylase gene part could be selectively expressed in the
leaves of a plant (e.g., corn, cotton) by placing the gene part

programs. Preferred computer program methods to determine

identity and similarity betWeen tWo sequences include, but
are not limited to, the GCG program package (Devereux, J ., et

al., Nucleic Acids Research 12(1): 387 (1984)), BLASTP,

under the control of a light-inducible promoter such as the

BLASTN, and FASTA (Atschul, S. F. et al., J. Molec. Biol.
215: 403-410 (1990). The BLAST X program is publicly
available from NCBI and other sources (BLAST Manual,
Altschul, S., et al., NCBI NLM NIH Bethesda, Md. 20894;
Altschul, S., et al., J. Mol. Biol. 215: 403-410 (1990). As an
illustration, by a polynucleotide having a nucleotide sequence
having at least, for example, 95% “identity” to a reference
nucleotide sequence, it is intended that the nucleotide
sequence of the polynucleotide is identical to the reference
sequence except that the polynucleotide sequence may
include up to ?ve point mutations per each 100 nucleotides of

promoter of the ribulose-1,5-bisphosphate carboxylase small
subunit gene of the plant itself or of another plant such as pea
as disclosed in US. Pat. No. 5,254,799. Another alternative is
to use a promoter Whose expression is inducible (e. g., by

temperature or chemical factors).
The peptide deformylase gene or part thereof may be
inserted in the plant genome so that the inserted gene part is

upstream (i.e., 5') of suitable 3' end transcription regulation

signals (i.e., transcript formation and polyadenylation sig
nals). This is preferably accomplished by inserting the pep
tide deformylase chimeric gene in the plant cell genome.

Preferred polyadenylation and transcript formation signals
include those of the octopine synthase gene (Gielen et al.,

20

EMBO J. 3:835-845 (1984)) and the T-DNA gene 7 (Velten
and Schell, Nucleic Acids Research 13:6981-6998 (1985)),
Which act as 3'-untranslated DNA sequences in transformed

plant cells.

25

The peptide deformylase gene or part thereof can option
ally be inserted in the plant genome as a hybrid gene (U .S. Pat.
No. 5,254,799; Vaeck et al., J. Econ. Entomol 55: 140 (1962))

positions of the reference nucleotide sequence or anyWhere
vidually among nucleotides in the reference sequence or in
30
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A “host cell” is a cell Which has been transformed or

transfected, or is capable of transformation or transfection by
an exogenous polynucleotide sequence.
“Homologous” or “substantial identity,” When referring to

40

nucleic acids as used herein denotes a characteristic of a

nucleic acid sequence, Wherein a nucleic acid sequence has at
least about 70 percent sequence identity as compared to a

reference sequence, typically at least about 85 percent
sequence identity, and preferably at least about 95 percent

percentage of sequence identity is calculated excluding small
deletions or additions Which total less than 25 percent of the
reference sequence. “Identity,” as known in the art, is a rela
50

otide sequences, as the case may be, as determined by the

sity Press, NeW York, 1988; Biocomputing: Informatics and
Genome Projects, Smith, D. W., ed., Academic Press, NeW
York, 1993; Computer Analysis of Sequence Data, Part I,
Grif?n, A. M., and Grif?n, H. G., eds., Humana Press, NeW
Jersey, 1994; Sequence Analysis in Molecular Biology, von
Heinje, G., Academic Press, 1987; and Sequence Analysis
Primer, Gribskov, M. and Devereux, J ., eds., M Stockton

Press, NeW York, 1991; and Carillo, H., and Lipman, D.,
SIAM J. Applied Math., 48: 1073 (1988). Preferred methods

or carboxy terminal positions of the reference amino acid
sequence or anyWhere betWeen those terminal positions,
interspersed either individually among residues in the refer
ence sequence or in one or more contiguous groups Within the

ing the sequences. In the art, “identity” also means the degree
of sequence relatedness betWeen polypeptide or polynucle

match betWeen strings of such sequences. “Identity” and
“similarity” can be readily calculated by knoWn methods,
including but not limited to those described in (Computa
tional Molecular Biology, Lesk, A. M., ed., Oxford Univer

reference amino acid sequence, it is intended that the amino
acid sequence of the polypeptide is identical to the reference
sequence except that the polypeptide sequence may include
up to ?ve amino acid alterations per each 100 amino acids of
the reference amino acid. In other Words, to obtain a polypep
tide having an amino acid sequence at least 95% identical to
a reference amino acid sequence, up to 5% of the amino acid
residues in the reference sequence may be deleted or substi
tuted With another amino acid, or a number of amino acids up
to 5% of the total amino acid residues in the reference
sequence may be inserted into the reference sequence. These
alterations of the reference sequence may occur at the amino
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sequence identity as compared to a reference sequence. The

tionship betWeen tWo or more polypeptide sequences or tWo
or more polynucleotide sequences, as determined by compar

one or more contiguous groups Within the reference

sequence. Analogously, by a polypeptide having an amino
acid sequence having at least, for example, 95% identity to a

GLOSSARY

The folloWing de?nitions are provided to facilitate under
standing of certain terms used frequently herein.

identical to a reference nucleotide sequence, up to 5% of the
nucleotides in the reference sequence may be deleted or sub
stituted With another nucleotide, or a number of nucleotides
up to 5% of the total nucleotides in the reference sequence
may be inserted into the reference sequence. These mutations
of the reference sequence may occur at the 5' or 3' terminal

betWeen those terminal positions, interspersed either indi

under the control of the same promoter as a selectable marker

gene, such as the neo gene (EP 0 242 236) encoding kanamy
cin resistance, so that the plant expresses a fusion protein.

the reference nucleotide sequence. In other Words, to obtain a
polynucleotide having a nucleotide sequence at least 95%

55

reference sequence. The reference sequence in the instant
case may be the sequence of Atdef1, Atdef2, AtDEFl, or
AtDEF2.
“Isolated” means altered “by the hand of man” from its
natural state, i.e., if it occurs in nature, it has been changed or

removed from its original environment, or both. For example,
a polynucleotide or a polypeptide naturally present in a living
organism is not “isolated”, but the same polynucleotide or

polypeptide separated from the coexisting materials of its
natural state is “isolated”, as the term is employed herein.

“Polynucleotide(s)” generally refers to any polyribonucle
60

otide or polydeoxyribonucleotide, Which may be unmodi?ed
RNA or DNA or modi?ed RNA or DNA. “Polynucleotide(s)”

include, Without limitation, single- and double-stranded
DNA, DNA that is a mixture of single- and double-stranded

regions or single-, double- and triple-stranded regions,
65

single- and double-stranded RNA, and RNA that is mixture of
single- and double-stranded regions, hybrid molecules com
prising DNA and RNA that may be single-stranded or, more
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typically, double-stranded, or triple-stranded regions, or a

(1990) and Rattan et al., Protein Synthesis Posttranslational

mixture of single- and double-stranded-regions. In addition,

Modi?cations and Aging, Ann. NY. Acad. Sci. 663:48-62
(1992)). Polypeptides may be branched or cyclic, With or

“polynucleotide” as used herein refers to triple-stranded
regions comprising RNA or DNA or both RNA and DNA.

Without branching. Cyclic, branched and branched circular
polypeptides may result from post-translational natural pro
cesses and may be made by entirely synthetic methods, as

The strands in such regions may be from the same molecule or
from different molecules. The regions may include all of one
or more of the molecules, but more typically involve only a
region of some of the molecules. One of the molecules of a

Well. The terms “peptide”, “polypeptide” or “protein” are

used interchangeably herein.
“Stringent hybridization conditions” refers to conditions
Which permit hybridization betWeen polynucleotides. Strin

triple-helical region often is an oligonucleotide. As used
herein, the term “polynucleotide(s)” also includes DNAs or
RNAs as described above that contain one or more modi?ed

gent conditions can be de?ned by salt concentration, the

bases. Thus, DNAs or RNAs With backbones modi?ed for

concentration of organic solvent (e.g., formamide), tempera
ture, and other conditions Well knoWn in the art. In particular,
stringency can be increased by reducing the concentration of

stability or for other reasons are “polynucleotide(s)” as that

term is intended herein. Moreover, DNAs or RNAs compris
ing unusual bases, such as inosine, or modi?ed bases, such as

salt, increasing the concentration of formamide, or raising the
hybridization temperature. For example, stringent salt con

tritylated bases, to name just tWo examples, are polynucle

centration Will ordinarily be less than about 750 mM NaCl
and 75 mM trisodium citrate, preferably less than about 500
mM NaCl and 50 mM tri sodium citrate, and mo st preferably

otides as the term is used herein. It Will be appreciated that a

great variety of modi?cations have been made to DNA and
RNA that serve many useful purposes knoWn to those of skill

in the art. The term “polynucleotide(s)” as it is employed
herein embraces such chemically, enzymatically or metaboli
cally modi?ed forms of polynucleotides, as Well as the chemi
cal forms of DNA and RNA characteristic of viruses and cells,

20

of organic solvent, e.g., formamide, While high stringency
hybridization can be obtained in the presence of at least about
35% formamide, and most preferably at least about 50%

formamide. Stringent temperature conditions Will ordinarily

including, for example, simple and complex cells. “Poly
nucleotide(s)” also embraces short polynucleotides often

25

referred to as oligonucleotide(s).

“Polypeptide(s)” refers to any peptide or protein compris
ing tWo or more amino acids joined to each other by peptide
bonds or modi?ed peptide bonds. “Polypeptide(s)” refers to
both short chains, commonly referred to as peptides, oli

sulfate (SDS), and the inclusion or exclusion of carrier DNA,
are Well knoWn to those skilled in the art. Various levels of
30

referred to as proteins. Polypeptides may contain amino acids
other than the 20 gene encoded amino acids. “Polypeptide(s)”
include those modi?ed either by natural processes, such as
35

tions are Well described in basic texts and in more detailed
monographs, as Well as in a voluminous research literature,
and they are Well knoWn to those of skill in the art. It Will be

appreciated that the same type of modi?cation may be present
in the same or varying degree at several sites in a given

40

types of modi?cations. Modi?cations can occur anyWhere in

a polypeptide, including the peptide backbone, the amino
45

Modi?cations include, for example, acetylation, acylation,

typical variant of a polynucleotide differs in nucleotide
sequence from another reference polynucleotide. Changes in

covalent attachment of a heme moiety, covalent attachment of
a nucleotide or nucleotide derivative, covalent attachment of
50

dylinositol, cross-linking, cyclization, disul?de bond forma
tion, demethylation, formation of covalent cross-links, for
mation of cysteine, formation of pyroglutamate, formylation,
gamma-carboxylation, glycosylation, GPI anchor formation,

hydroxylation, iodination, methylation, myristoylation, oxi
dation, proteolytic processing, phosphorylation, prenylation,
racemization, glycosylation, lipid attachment, sulfation,
gamma-carboxylation of glutamic acid residues, hydroxyla

55

sequence, as discussed beloW. A typical variant of a polypep
tide differs in amino acid sequence from another, reference
polypeptide. Generally, differences are limited so that the
sequences of the reference polypeptide and the variant are

closely similar overall and, in many regions, identical. A
variant and reference polypeptide may differ in amino acid
60

lation, and ubiquitination. (See, for example, Proteins-struc
ture And Molecular Properties, 2nd Ed., T. E. Creighton, W.
H. Freeman and Company, NeW York (1993) and Wold, F.,
Posttranslational Protein Modi?cations: Perspectives and
Prospects, pgs. 1-12 in Posttranslational Covalent Modi?ca
tion of Proteins, B. C. Johnson, Ed., Academic Press, NeW
York (1983); Seifter et al., Meth. Enzymol. 182:626-646

the nucleotide sequence of the variant may or may not alter

the amino acid sequence of a polypeptide encoded by the

reference polynucleotide. Nucleotide changes may result in
amino acid substitutions, additions, deletions, fusions and
truncations in the polypeptide encoded by the reference

tion and ADP-ribosylation, selenoylation, transfer-RNA
mediated addition of amino acids to proteins, such as arginy

15 mM NaCl, 1.5 mM trisodium citrate, and 0.1% SDS.
Additional variations on these conditions Will be readily
apparent to those skilled in the art.
“Variant(s)” as the term is used herein, is a polynucleotide
or polypeptide that differs from a reference polynucleotide or

polypeptide respectively, but retains essential properties. A

ADP-ribosylation, amidation, covalent attachment of ?avin,
a lipid or lipid derivative, covalent attachment of phosphoti

stringency are accomplished by combining these various con
ditions as needed. The Washing steps Which folloW hybrid
ization can also vary in stringency. Wash stringency condi
tions can be de?ned by salt concentration and by temperature.
As above, Wash stringency can be increased by decreasing
salt concentration or by increasing temperature. For example,
stringent salt concentration for the Wash steps Will preferably
be less than about 30 mM NaCl and 3 mM trisodium citrate,
and most preferably less than about 15 mM NaCl and 1 .5 mM
trisodium citrate. Stringent temperature conditions for the
Wash steps Will ordinarily include temperature of at least
about 25° C., more preferably of at least about 42° C., and
most preferably of at least about 68° C. Will occur at 42° C. in

polypeptide. Also, a given polypeptide may contain many
acid side-chains, and the amino or carboxyl termini.

include temperatures of at least about 30° C., more preferably
of at least about 37° C. and most preferably of at least about
42° C. Varying additional parameters, such as hybridization

time, the concentration of detergent, e.g., sodium dodecyl

gopeptides and oligomers and to longer chains generally

processing and other post-translational modi?cations, but
also by chemical modi?cation techniques. Such modi?ca

less than about 250 mM NaCl and 25 mM trisodium citrate.
LoW stringency hybridization can be obtained in the absence

sequence by one or more substitutions, additions, deletions in
any combination. A substituted or inserted amino acid residue
may or may not be one encoded by the genetic code. A variant
of a polynucleotide or polypeptide may be a naturally occur
ring such as an allelic variant, or it may be a variant that is not

knoWn to occur naturally. Non-naturally occurring variants of
65

polynucleotides and polypeptides may be made by mutagen
esis techniques, by direct synthesis, and by other recombinant
methods knoWn to skilled artisans.
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Polymerase Chain Reaction

All references cited in the present application are expressly

incorporated by reference herein.

The ?rst strand cDNA was used as a PCR template. Rob

oCycler® Gradient 40 Temperature Cycler was used with the

The following examples are provided for illustrative pur

following temperature regime:

poses and are not intended to limit the scope of the invention

as claimed herein. Any variations in the exempli?ed compo
sitions and methods that occur to the skilled artisan are

intended to fall within the scope of the present invention.

1 cycle
35 cycles
1 cycle

EXAMPLE 1

The reaction product was analyZed by adding an aliquot of
the reaction mixture to loading dye and loading into wells of
a 1% TAE gel and subjecting the gel to electrophoresis. (FIG.

Identi?cation and Isolation of an Arabidopsis

Peptide Deformylase Gene (Atdef1)

2.)

The Arabidopsis Zhaliana genome sequencing project
recently annotated a gene (AC007591; F9L1.35

3 minutes 94° C.
1 minute 94° C., 1 minute 50° C., 1 minute 72° C.
10 minutes 72° C.

Ligation to pCR®2.1 Vector
The amplicon of the expected siZe, 630 bp, was cloned into

at

www.ncbi.nlm.nih.gov;) as a putative peptide deformylase
based on substantial homology to Chlamydia pneumoniae

pCR®2.1 TA-vector (Invitrogen). (See FIG. 2.) The 10 pl
ligation reaction mixture contained 1-2 pl of PCR product, 1

(AE001687) protein. An identi?able chloroplast targeting
sequence was also identi?ed. The predicted protein sequence
was analyZed using the ChloroP program (Emanuelsson et
al., Protein Science 8:978-984 (1999)), which revealed a
putative transit peptide of 50 amino acids. (See FIGS. 1A and

1B.)

20

sterile water to a total volume of 10 pl. One microliter of T4

DNA Ligase (4.0 Weiss units) was added to the reaction
mixture and the ligation reaction was incubated at 14° C. for
a 14-16 hours.
25

Construction of a Peptide Deformylase Clone (Atdef1)
Experiments were initiated to amplify Arabidopsis

Zhaliana peptide deformylase complementary DNA (cDNA)
using Reverse Transcriptase-Polymerase Chain Reaction

(RT-PCR).

30

Isolation of Arabidopsis Zhaliana RNA
Total RNA was isolated using TRIZolTM reagent from

GIBCO BRL, following the manufacturer’s protocol. Brie?y,
the procedure was as follows: 0.5 gm Arabidopsis Zhaliana
cv. Columbia leaves were homogenized in 5 ml of TRIZolTM

35

a power setting of 5. Following a 5 minute room temperature
40

for 10 minutes at 4° C. The RNA pellet was washed with 1.0
45

were added. The tube was capped tightly and shaken horiZon
tally at 37° C. for 60 minutes.
Approximately, 50-100 pl from each transformation were

spread on a prewarmed LB-agar plate containing the 100
pg/ml ampicillin and X-Gal, and the inverted plates were

Sequence Analysis
ture. Sequence determinations were carried out by the

First strand cDNA was prepared from RNA isolated from

dideoxynucleotide chain termination procedure (Sanger et al.
50

146 and 147 having the sequence 5' TTG TCG ACA AAA
GCC GGT TGG 3' (SEQ ID NO: 1) and 5' TCA TTG AGG

(1977) Proc. Natl. Acad. Sci. USA 74:8073-8077), with an

automated ?uorescence-based system (Applied Biosystems,
Foster City, Calif.). The DNA sequence of the Atdef1 insert is
identical to the deduced [computer generated] cDNA
sequence of gene AC 0075912 in the Arabidopsis genome

TCC GAG CTT AG 3' (SEQ ID NO: 2), respectively. The
reverse transcription reaction was carried out in a 20 ul reac

tion volume containing 4 ul of RNA (150 ng/ml), 1.5 ul of 3'
antisense oligo (likely RLH 147) (10 uM stock diluted to a
?nal concentration of 0.75 uM), 8.5 ul of water, 1 ul of 20 mM
each dATP, dGTP, dCTP, dTTP (?nal concentration of 1
mM), 2 ul of MgCl2 (to ?nal concentration of 5 mM), 2 ul of
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PCR buffer (10><200 mM Tris-HCl, pH 8.4, 500 mM KCl)
used according to the manufacturer’s instructions (Gibco

60

sequence.
EXAMPLE 2

Expression and Puri?cation of Arabidopsis Zhaliana

BRLTM Life TechnologiesTM ) and 200 units of MMLV

Peptide Deformylase (AtDEF 1)
Cloning into pLEX

reverse transcriptase (Gibco BRLTM Life TechnologiesTM .)
for 30 minutes at 42° C. in a RoboCyclerTM Gradient 40

92037). This reaction was terminated by incubation at 99° C
for 5 minutes and subsequently cooled to 6° C.

and incubated for 2 minutes. Next, 250 pl of room tempera
ture SOC medium (formulation per liter: 20 g tryptone, 5 g

?rmed that this plasmid had the expected and desired struc

First Strand cDNA Synthesis

Temperature Cycler (StratageneTM.; La Jolla, Calif., USA

were added into a vial of One ShotTM cells and mixed gently.
The mixture was incubated on ice for 30 minutes. The cells
were subjected to heat shock for 30 seconds at 42° C. without
shaking. The cells were then immediately transferred to ice

Determination of the DNA sequence of the insert con

treated water.

Arabidopsis Zhaliana cells using gene speci?c primers RLH

sample was mixed by stirring gently with a pipette tip. After
wards, 2 pl of the TA Cloning® reaction (ligation reaction)

incubated overnight at 37° C. Approximately 10 white or light
blue colonies were picked for analysis.

The precipitate was collected by centrifugation at 12,000><g
ml of 70% ethanol, dried brie?y, and resuspended in DEPC

Transformation
To each vial of One ShotTM INVotF' competent cells (Invit
rogen) were added 2 pl of 0.5 M [3-mercaptoethanol and the

yeast extract, 0.5 g NaCl, 0.95 g MgCl2, and 20 mM glucose)

reagent with a Polytron homo geniZer for 10-15 seconds using
incubation, 1.0 ml of chloroform was added. The samples
were mixed and centrifuged at 12,000><g for 15 minutes at 4°
C. Following centrifugation, the aqueous phase was removed
and the RNA precipitated with 2.5 ml of isopropyl alcohol.

pl of 10x ligation buffer, 2 pl of pCR®2.1 vector (25 ng/pl),

65

Restriction Endonuclease Digestion
The peptide deformylase gene (from Example I) was
digested with NdeI and XhoI and ligated into pLEX (Invitro
gen) that had been digested with NdeI and XhoI restriction
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endonucleases according to the manufacturer’s protocol (PL
Expression system version D 180129).
Ligation to pLEX
The 10 pl ligation reaction contained 1 pl of linearized
pLEX vector (50-200 ng), 2 pl of lineariZed insert (5 -200 ng),
1 pl of 10x ligation Buffer (should have ATP), sterile Water to
9 pl, and 1 pl of T4 DNA Ligase (0.5 Weiss Units). The

time sample. The supernatant Was decanted and the cell pellet
Was froZen at —20° C. until ready to assay. The cell culture Was
returned to the incubator.
To the cell culture, tryptophan Was added to a ?nal concen

tration of 100 pg/ml using the 10 mg/ml stock solution
included in the kit. The culture Was transferred to 37° C. and

incubated With shaking (200-225 rpm).
At time t:1 hour, the OD550 Was read and recorded. Then,
a 1 ml sample Was taken and placed into the microcentrifuge

reaction mixture Was incubated for 12-16 hours at 15° C.

Transformation
Three to ?ve microliters of the ligation reaction Were added
to a separate tube of competent cells (GI724) and mixed

tube labeled “tIl”. The cell culture Was returned to the incu

bator to continue groWing. The 1 ml sample Was centrifuged
at maximum speed for 2-3 minutes, the supernatant decanted,
and the cell pellet froZen at —20° C. This Was repeated at t:2,
3, and 4 hours.
On Day 4, the ?ve samples Were removed from the freeZer
and placed on ice. Each cell pellet Was resuspended in 500 pl
cold (+4° C.) TE Buffer, pH 7.5 and kept on ice. Using a
hand-held sonicator With a micro-tip, each sample Was soni

gently With a pipette tip (Without PIPETTING UP AND
DOWN). The tubes Were incubated on ice for 30 minutes. All
tubes Were then transferred to 42° C. Water bath and incubated

for 90 seconds, then placed on ice for 1-2 minutes. Then, 800
pl of room temperature SOC medium Were added to each tube
and the tubes Were shaken at 225 rpm for 45 minutes at 37° C.

Afterwards, 100 pl and 300 pl of each transformation mix
Were plated on RMG-Amp (formulation of RMG per liter: 6

cated one at a time With tWo or three 10 second bursts. The
20

g Na2HPO4, 3 g KH2PO4, 0.5 g NaCl, 1 g NH4Cl, 20 g
Casamino Acids, 5 g glucose, 20.33 mg MgCl2, 15 g Agar

plus 100 pg/ml ampicillin) transformation plates, the liquid

rapid sonication-freeZe-thaW cycles Were performed. Steps 3

Was alloWed to dry, and the inverted plates Were incubated at

30° C. overnight.

25

Plates Were removed from the incubator and 10 transfor
mants Were picked and inoculated into 2-5 ml of RM medium

(formulationper liter: 6 g Na2HPO4, 3 g KH2PO4, 0.5 g NaCl,
1 g NH4Cl, 20 g Casamino Acids, 10 ml glycerol, 20.33 mg
MgCl2 With 100 pg/ml ampicillin). The inoculants Were incu

Peptide deformylase protein expressed in bacteria Were
30

35

(1989) Molecular Cloning: A Laboratory Manual, 2'” Ed.
Cold Spring Harbor Laboratory Press, NY, USA, pages 1.25
1.28), resuspendingthe ?nal DNA pellet in 20 pl 10 mM Tris,
puri?ed by streaking for single colonies on RMG-Amp plates
before making glycerol stocks.

40

fully and extensively. After centrifugation (7000>< g for 10
minutes) the supernatant Was removed and the pellet Was

resuspended in cold Triton buffer (20 mM Tris-HCl, pH 7.5;
0.5% (v/v) Triton-X-100, 1 mM EDTA, 10 mM 2-mercapto

using the pLEX Forward Sequencing Primer and the AspA
Reverse Sequencing Primer (Invitrogen). Sequence determi

ethanol). The sample Was mixed Well and centrifuged as
above. The pellet Was Washed at least once more With Triton

nations Were carried out by the dideoxynucleotide chain ter

buffer until it appeared White. The pellet Was Washed once

mination procedure Sanger et al. (1977) Proc. Natl.Acad. Sci.
50

at —80° C. The inclusionbodies had to be solubiliZed With 6 M

Expression and Isolation of AtDEFl

guanidine-HCl prior to the in vitro chloroplast import experi

On Day 1, the clone of interest Was streaked out on a

55 ment.

EXAMPLE 3

In vitro Chloroplast Import of Peptide Deformylase

Was inoculated and incubated at 30° C. at 200-225 rpm in a
60

Although signal peptides vary in amino acid sequence and

On Day 3, 10 ml of fresh Induction Medium Was inoculated
in a 25 ml culture ?ask to an OD550 of 0.1 using the overnight

length, the tendencies for certain classes of amino acids as
Well as semi-conserved cleavage sites have facilitated com

culture. This culture Was groWn at 30° C. to an OD550 of 0.5

(approximately 2-3 hours). When an OD550 of 0.5 Was
reached, a 1 ml aliquot Was transferred to a microcentrifuge

tube labeled “t:0”, and the tube Was centrifuged for 2-3
minutes at maximum speed to pellet the cells. This is the Zero

With cold Tris buffer (50 mM Tris-HCl, pH 7.6; 1 mM EDTA;
10 mM DTT). The collected inclusion bodies Were ?nally
resuspended in Tris buffer and stored as a suspension in 50 pl

system (Applied Biosystems, Foster City, Calif.).

shaking incubator overnight.

detergent buffer (20 mM Tris-HCl, pH 7. 5, 200 mM NaCl, 1%
(W/v) deoxycholate, 1% (W/v) Nonidet P-40, 2 mM EDTA, 10
mM 2-mercaptoethanol) Were added and mixed very care

To con?rm the peptide deformylase DNA sequence Was in
frame With the initiating ATG, the construct Was sequenced

RMG-Amp plate With 100 pg/ml ampicillin and groWn at 30°
C. until single colonies Were visible (12-16 hours).
On Day 2 and using a single colony from the plate from
Day 1, 1 ml of RM medium containing 100 pg/ml ampicillin

(W/v) sucrose, 1 mM EDTA). LysoZyme Was added to a ?nal
concentration of 2 mg/ml and the mixture Was incubated for

30 minutes on ice. After addition of MgCl2 (0.5 mM) and
MnCl2 (0.05 mM) the culture Was treated With DNase I (40
pg/ml) for another 30 minutes on ice. Next, 2 volumes of cold

Sequence Analysis

USA 74:8073-8077) With an automated ?uorescence-based

synthesiZed as insoluble inclusion bodies, Which can be iso

lated rather quickly (Paulsen et al. 1990; Waegemann and
S011, Methods in Cell Biology 50:255-267)). The bacteria
Were harvested by centrifugation (7000><g for 5 minutes) and
resuspended in cold lysis buffer (50 mM Tris-HCl, pH 8, 25%

Mini-plasmid Preparation

pH 8.0 With 0.1 pg/ml RNase A. The desired clone Was

and 4 Were repeated until three sonication-freeZe-thaW cycles
Were completed for all samples. After the last thaW, all tubes
Were centrifuged at maximum speed for 5-10 minutes at +4°
C. to pellet cell debris and insoluble matter.

bated at 30° C. overnight.

Plasmid DNA Was isolated by miniprep for restriction
analysis and sequencing. The miniprep DNA isolation Was
conducted using a small-scale procedure (Sambrook, 1., et al.

lysate Was subjected to ?ash freeZing in a dry ice/ethanol
bath.
The lysates Were quickly thaWed at 37° C. and tWo more
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puter modeling and prediction of signal sequences Within a
putative nuclear-encoded chloroplast protein. A neural net
Work based predictor has recently been developed that dis
criminates transit peptide sequences from non-transit peptide
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sequences with high sensitivity and speci?city. (Emanuelsson

The AtDEFl antibody (Rabbit 95728) at 1150,000 detected
an expected siZe protein from ~100 pg Arabidopsis total

et al., Protein Science 81978-984 (1999)).

protein extract (See FIG. 4.)

The Arabidpsis Zhaliana peptide deformylase predicted
protein sequence was analyzed using the neural network
based predictor (Emanuelsson et al. Protein Science (1999)
81978-984) ChloroP program, which predicted a signal pep

EXAMPLE 5

Assay for in vivo Herbicidal Activity

tide of 50 amino acids with a cleavage site between amino

acids 50 and 51. Since signal peptides are capable of mediat

Pea plants (Pisum salivum L. cv. Laxton’s Progress No. 9)

ing precise chloroplast targeting and import, in vitro chloro
plast import experiments were conducted using the peptide
deformylase protein. The peptide deformylase protein would
be predicted to function in the chloroplast due to it’s prokary
otic lineage. Considering the dif?culty in isolating an appre
ciable amount of chloroplast from young Arabidopsis plants,
import studies were conducted using pea chloroplasts, which
have been extensively used to study import of a wide variety
of other precursor proteins.
Chloroplast were isolated (Mills and Joy, Planta 148175-83

were sown in 46x62 cm ?ats of MetroMix 360 and grown for

10-12 days in a greenhouse (minimum night temperature of
300 C.) as described by Wang, P., Royer, M., and HoutZ, R. L.

Af?nity puri?cation of ribulose-1,5-bisphosphate carboxy
lase/oxygenase large subunit epsilon N-methyltransferase.
Protein Expression and Puri?cation 61528-526 (1995).
Ten-day old pea plants were treated with approximately
100-200 pl actinonin (?nal concentration. 2.5 mg/ml perplant
in 0.1% Tween-20). Control plants were treated with 0.1%
Tween-20. As shown in FIG. 5, observable alterations in plant
20

(1980)) from 8-10 day old pea seedlings and peptide

were clearly visible within 48 hours after treatment with
actinonin.

deformylase was isolated as a bacterially expressed inclusion

body (Waegemann and S011, Methods in Cell Biology
501255-267). A typical 100 pl import assay contained 330
mM sorbitol, 50 mM Hepes/KOH, pH 7.6, 3 mM MgSO4, 10

growth, i.e., stunting and yellowing of pea plants, were evi
dent after application of 2.5 mg/ml actinonin. The changes

EXAMPLE 6

25

mM methionine, 20 mM K-gluconate, 10 mM NaHCO3, 2%
BSA, 3 mM ATP, 15-20 mg chlorophyll and 1-2 pl 35S

methionine labeled peptide deformylase precursor protein
(120-600,000 dpm/pl, in 6 M guanidine-HCl). Incubations

Cloning of Atdef2
30

were performed at room temperature with gentle agitation for

0, 15 or 30 minutes. Following incubation, the chloroplasts
were re-isolated through 40% percoll gradients, lysed, resus

pended in SDS loading buffer and analyZed by SDS-PAGE.
The bacterially-expressed Arabidopsis Zhaliana peptide
deformylase protein was imported into isolated pea chloro
plasts under standard import conditions and processed to a
mature form once inside the plastid. To con?rm chloroplast
localiZation of the mature form of peptide deformylase, chlo

domain with no other sequence homologies in the sequence.
35

and TargetP v1.0 (www.cbs.dtu.dk/services/TargetP) predict
40

roplasts were treated with thermolysin (0.1 mg/mg chloro

the protein to the chloroplast.
Primers were designed to amplify PCR products encoding
the entire putative protein and the ChloroP-predicted chloro

plast-length protein, respectivelyi(RLH2191 5'-CATATG
GCCGTCTGTAACTGCTTC-3' (SEQ ID NO: 3) and
RLH2201
45

proteolytic (thermolysin) digestion (See FIG. 3.). These
import studies prove that Arabidopsis Zhaliana peptide

Homology was to polypeptide deformylase from Aquifex
aeolicus, PIR1C70352.
Both ChloroP v1.1 (130.225.67.199/services/ChloroP1)
T15N1.150 to have a 56 amino acid transit peptide to target

phyll) for 20 minutes on ice following the initial 30 minute
incubation. Thermolysin is widely used to con?rm precursor

import into chloroplasts (See, e.g., Cline et al., Plant Physiol
751675-678 (1984), Waegemann and S011, Methods in Cell
Biology 181255-266). The mature form of peptide deforrny
lase imported into isolated chloroplasts was protected from

A database search revealed that another Arabidopsis
Zhaliana genomic sequence (AL163792; ATT15N1 at
www.ncbi.nlm.nih.gov; T15N1.150) annotated as “Homol
ogy with polypeptide deformylase” is restricted to a small

50

deformylase contains a chloroplast transit peptide and that
this cleavable signal sequence is capable and su?icient to
direct import of peptide deformylase into isolated chloro

5'-CATATGGCAGAAGTAAAGCGCGTCTC-3'

(SEQ ID NO: 4). These primers included an Ndel restriction
enZyme site for eventual subcloning into expression vector,
pET23. Primers against the 3' end of the genomic sequence
encoding the C-terrninus of the putative sequence were
designed to include the endogenous stop codon and remove
the stop codon resulting in a C-terminal 6x. -His tag upon

subcloning in the expression vector, respectively (RLH2211
5'-CTCGAGTCAACQTTTGCCAAAACC-3' (SEQ ID

plasts.
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NO: 5); RLH22215'-CTCGAGACGTTTGCCAAAAC
CAAC-3' (SEQ ID NO: 6)). These 3'-end primers included a
Xhol restriction enZyme site for eventual subcloning into

expression vector, pET23.

EXAMPLE 4

RT-PCR

Arabidopsis Zhaliana (AtDEFl) Antibody
Strategic BioSolutions (PO. Box 1319, Ramona, Calif.

Upon appropriate dilution of the primer stock for a 10 pM
working solution, an RT reaction was set up using Arabidop
sis Zhaliana cv. Columbia leaf RNA isolated by the TRlZolTM

92065; 1 800 481 9737) was sent 1 ml ofthe mature form of

Reagent (Gibco BRL® Life TechnologiesTM) as previously
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AtDEFl (i.e., ChloroP predicted transit peptide removed;
~23 kDa) in 6M urea, 50 mM Tris, pH 8.2, 5 mM MgCl2, 1
mM EDTA at 4 mg/ml for use in their “Fast Protocol” (50

days) with 2 rabbits. Strategic Biosolutions supplied 1 pre
bleed, 3 bleeds and the ?nal exsanguination.
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described. The 20 pl reaction contained 2 pl of 10x Gibco
BRL® Life TechnologiesTM PCR Reaction Buffer (200 mM
Tris-HCl, pH 8.4, 500 mM KCl), 2 pl of 50 mM Gibco
magnesium chloride (?nal concentration 5 mM), 1 pl of 20

mM dideoxynucleotides (?nal concentration 1 mM), 11.5 pl

